检索

标题
作者
Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors
Maev I., Andreev D., Shaburov R., Zaborovsky A., Fomenko A., Sokolov P., Tsaregorodtsev S., Devkota M., Dicheva D., Cheremushkin S., Cheremushkinа N., Vychkin A.
Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry
Aksenova A., Serov I., Belova O., Rachkova S., Chazova I.
The high-dose dual therapy for eradication of Helicobacter pylori: efficacy and safety
Bakulina N., Ponomarenko V., Kerimova A., Thai Hien T., Shikhmagomedova A., Veliev A., Savilova I.
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Karaseva E., Martynov V., Filatova T., Maleev V., Grishin V., Pronin N., Verbitskaya E., Popova V.
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A., Kamynina L., Ametov A., Kamynina L.
Antiviral therapy of chronic hepatitis C: 30 years success story
Abdurakhmanov D., Rozina T., Nikulkina E., Burnevich E., Tanashuk E., Severov M., Filatova A., Milovanova S., Karpov V., Moiseev S.
The role of matrix metalloproteinases in pathogenesis of renal disease
Bobkova I., Kozlovskaia L., Li O.
Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors
Karateev A., Nasonova V.
Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities
Zyryanov S., Butranova O., Gaidai D., Kryshen K.
Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up
Aronova E., Lukina G., Glukhova S., Gridneva G., Kudryavtseva A.
The use of Tofacitinib in the treatment of inflammatory bowel disease
Nasonov E., Abdulganieva D., Fairushina I.
Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease
Maev I., Barkalova E., Ovsepyan M., Kucheryavyi Y., Andreev D.
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A., Gusenbekova D.
Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
Nasonov E., Karateev D., Lukina G.
Diagnosis and treatment of gastroesophageal reflux disease
Trukhmanov A., Trukhmanov A.
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
Novikova D., Popkova T., Nasonov E., Novikova D., Popkova T., Nasonov E.
ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
Schekotov V.
Change in the activity of angiotensin-converting enzyme in pneumonia and chronic obstructive lung diseases
Altshuler B., Roitman A., Fedorova T., Novazhenov V., Belkov S., Gordeev M., Yarovaya G., Neshkova Y., Ustinov A.
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
Nasonov E.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе
Khokhlov A., Mariandyshev A., Shcherbakova V., Ozerova I., Kazaishvili Y., Igumnova O., Bolgarina A., Rudoy B.
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)
Mariandyshev A., Khokhlov A., Smerdin S., Shcherbakova V., Igumnova O., Ozerova I., Bolgarina A., Nikitina N.
Problems of nociception in gastroesophageal reflux disease: diagnostics and treatment of irritated oesophagus
Sablin O., Ilchishina T.
Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C
Batskikh S., Karandashova I., Neverov A., Chulanov V.
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
Samsonov A., Grechushnikov V., Andreev D., Iurenev G., Korovina T., Lezhneva I., Maev I.
Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects
Turkina A., Chelysheva E.
Fozinopril in the treatment of cardiorenal syndrome in chronic cardiac failure
Tereshchenko S., Zhirov I., Tereschenko S., Zhirov I.
How to diagnose functional (non-ulcerative) dyspepsia (a review)
Маеу I., Vyuchnova Y., Lebedeva Y., Yakimova S.
ACE inhibitor quinapril in the treatment of chronic cardiac failure
Gadzhiev A.
Rebamipide: thirty years of experience. A review
Bakulina N., Ponomarenko V., Bakulin I.
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O., Evdokimova N., Timoshchenko O., Latyntseva L.
Modern approaches to conservative therapy of polycystic kidney disease
Rudenko T., Bobkova I., Stavrovskaya E.
Diagnostics and treatment challenges of Ph-like acute lymphoblastic leukemia: a description of 3 clinical cases
ZARUBINA K., PAROVICHNIKOVA E., BASKHAEVA G., KRASILNIKOVA A., GAVRILINA O., BIDERMAN B., SUDARIKOV A., BONDARENKO S., DAVYDOVA Y., GALTSEVA I., SOKOLOV A., TROITSKAYA V., SAVCHENKO V.
Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
Pimanov S., Makarenko E., Dikareva E.
Eradication therapy for Helicobacter pylori infection: Review of world trends
Maev I., Kucheriavyĭ I., Andreev D., Barkalova E.
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
Ametov A., Kamynina L.
Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ACE inhibitors and calcium channel blockers?
Eliseev O., Eliseev O.
Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
Vinogradova O., Turkina A., Vorontsova A., Chelysheva E., Gusarova G., Kuznetsov S., Goryacheva S., Sokolova M., Abakumov E., Stakhina O., Domracheva E., Misyurin A., Khoroshko N., Vinogradova O., Turkina A., Vorontsova A., Chelysheva E., Gusarova G., Kuznetsov S., Goryacheva S., Sokolova M., Abakumov E., Stakhina O., Domracheva E., Misyurin A., Khoroshko N.
Erectile dysfunction in patients withischemic heart disease (review)
Gamidov S., Mazo E., Ovchinnikov R., Kurochkin E., Iremashvili V.
Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study
Myachikova V., Maslyanskiy A., Moiseeva O., Schedrova M., Egorova A., Ponomar Е., Samsonov M.
Efficacy and safety of the use of alirocumab in real clinical practice
Korneva V., Kuznetsova T., Scopets I., Vezikova N.
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Sturov N., Popov S., Mamporia N., Mager A.
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
Ostroumova O., Kochetkov A., Pereverzev A., Kravchenko E., Kazjulin A., Andreev D., Pavleeva E.
NSAID-induced enteropathy: the current state of the problem
Svistunov A., Osadchuk M., Kireeva N., Hudarova A., Achkasov E.
Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
Evsiutina I., Trukhmanov A.
Hypoglycemia in patients with type 2 diabetes mellitus: Safe solution of the dangerous problem
Shestakova M., Khalimov I.
Blood pressure variability and risk for complications in arterial hypertension
Ostroumova O.
Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
Gamidov S., Shcherbakov D., Tkhagapsoeva R., Koroteev R., Gamidov S., Shcherbakov D., Tkhagapsoyeva R., Koroteyev R.
Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosinkinases
Turkina A., Domracheva E., Vorontsova A., Aseeva E., Vinogradova O., Stakhina O., Gusarova G., Dyagileva O., Semenova E., Vakhrusheva M., Kolosheynova T., Abakumov E., Chelysheva E., Goryacheva S., Ivanova T., Zakharova E., Kolosova L., Zakharova A., Naumova I., Dyachenko L., Kulikov S., Kovaleva L., Khoroshko N., Turkina A., Domracheva E., Vorontsova A., Aseeva E., Vinogradova O., Stakhina O., Gusarova G., Dyagileva O., Semenova E., Vakhrusheva M., Kolosheinova T., Abakumov E., Chelysheva E., Goryacheva S., Ivanova T., Zakharova E., Kolosova L., Zakharova A., Naumova I., Dyachenko L., Kulikov S., Kovaleva L., Khoroshko N.
Progressiveazotemia provoked by ACE inhibitor in renal ischemia
Fomin V., Taronishvili О., Shvetsov M., Shilov E., Moiseev S., Kushnir V., Sorokin Y.
1 - 50 的 92 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语